Search Close Search
Search Close Search
Page Menu

Current Lab Members

  • Motahareh Arjomandnejad

    Motahareh Arjomandnejad

    Academic Role: Visiting Scholar


    BSc: Cellular and Molecular Biology, Shahid Chamran University, Ahvaz, Iran
    MS: Biotechnology, Alzahra University, Tehran, Iran 
    PhD: Medical Biotechnology, Tarbiat Modares University, Tehran, Iran (2014-)
    PhD: Immunology, UMass Chan Medical School, Worcester, MA (2019-)

    A limiting factor in the widespread application of gene therapy is the induction of an immune response. In systemic Adeno Associated Virus (AAV) gene therapy, there is an immune response to both the AAV vehicle and the introduced transgene. My project focuses on generation of chimeric antigen receptor regulatory T cells (CAR-Tregs) to suppress an immune response against AAV gene therapy and the introduced transgene.

  • Meghan Blackwood

    Meghan Blackwood

    Academic Role: Research Associate II

    Education: BS - Biology, UMass Dartmouth

    Joinied the Flotte Lab in 2020

  • Ishani Dasgupta

    Ishani Dasgupta

    Academic Role: Postdoctoral Associate


    PhD - Molecular and Cell Biology, Nanyang Technological University

    MS - Biotechnology, University of Calcutta

    BS - Microbiology, University of Calcutta

    Ishani also serves as the Events Director of Central Mass chapter of AWIS (Association for Women in Science)

    Joined the Flotte Lab in 2020

  • Tommy Nixon

    Tommy Nixon

    Academic Role: Research Technician

    Education: BA - Chemistry, College of the Holy Cross

    Joinied the Flotte Lab in 2019

  • Katelyn Sylvia

    Katelyn Sylvia

    Academic Role: Lab Manager/Research Associate II

    Education: BA - Biology, College of the Holy Cross

    Joined the Flotte Lab in 2019

  • Qiushi Tang

    Qiushi Tang

    Academic Role: Sr. Research Scientist

    Education: MS - Biochemistry, Jilin University

    BS - Chemistry, Jilin University 

    Working on recombinant adeno-associated virus (AAV) gene therapy vectors for alpha-1-antitrypsin deficiency (AAT). Focusing on dual-function AAV vector to augment wild-type(M-AAT) with simultaneous mutate AAT( Z-AAT) knockdown in a transgenic mouse model. My other focus is on NSG-PiZ  humanized mouse model to provide a platform for future studies of both cell based and genetic therapies of AAT deficiency

    Joined the Flotte Lab in 2001